Colgate Palmolive (India) Ltd. announces a leadership change

The regulatory filing establishes tenure and approval conditions, but does not disclose Manish Anandani’s remuneration package. Therefore, a quantitative comparison with predecessor compensation cannot be completed from the cited disclosures.

Analytical read: The only clear difference that can be established is structural: Anandani has been appointed under a fresh, fixed five-year mandate, rather than merely being described as continuing in office. The filing does not indicate whether his salary, annual incentive, long-term incentive, benefits or severance arrangements are higher or lower than those of his predecessors.

The latest Annual Report’s predecessor compensation figures and package components are not included in the cited material. Accordingly, any statement about how Anandani’s remuneration compares with Prabha Narasimhan’s or earlier MD & CEO packages would be unsupported. The comparison requires the Annual Report’s remuneration table and notes, including salary, perquisites, commission, variable pay, stock-based compensation and total remuneration.

^[1][2]

There is no substantiated Philippines market-share or growth KPI to attribute to Manish Anandani from the cited record—and the role itself appears to be misidentified. The available appointment coverage identifies him as Managing Director of Johnson & Johnson Philippines, now part of Kenvue, not Colgate-Palmolive Philippines. It separately describes his earlier Colgate-Palmolive roles across India, Indochina and the corporate office. ^[3]

What is established about the Philippines tenure

No Philippines-specific metric is reported for his tenure in the cited coverage—neither toothpaste market share, sales CAGR, category growth, oral-care penetration, nor premium-product mix. Consequently, there is no defensible basis to claim that he delivered a particular share gain or growth rate in that market.

The evidence supports a capability-based, rather than KPI-based, assessment: Anandani is described as having experience across sales, marketing, general management, digital/e-commerce transformation and market expansion. ^[4] That background is relevant to Colgate India’s agenda, but it is not proof of a directly comparable Philippines oral-care track record.

Comparison with Colgate India’s current priorities

The company’s investor site lists the 17 August 2026 Investor Day as the latest formal strategy presentation. ^[8] The quantified strategic evidence points to two linked levers: premiumization to raise value per user and higher oral-care consumption to expand the category.

Analytical read: the strategic fit is credible at the level of experience—consumer marketing, market expansion and customer development—but not yet demonstrated through disclosed Philippines performance metrics. The key evidence gap is whether Anandani previously converted those capabilities into measurable share gains, faster category growth or higher premium mix in the Philippines. Until such data is disclosed, the connection to Colgate India’s premiumization and penetration priorities remains a plausible leadership fit, not a verified performance precedent.

Verdict: Colgate-Palmolive India’s transition is best read as a hybrid global-talent move, not a pure internal succession. Prabha Narasimhan is moving from the India CEO role to an APAC marketing position within Colgate, while Manish Anandani is being appointed as India MD & CEO from Kenvue for a five-year term. ^[1] Contemporary coverage identifies Anandani as a Kenvue executive, rather than a current Colgate-Palmolive India insider. ^[9] The move therefore suggests continuity in the parent group’s leadership pipeline, combined with an external infusion of consumer-health and commercial experience.

Colgate’s succession model

• Internal mobility at the group level: Narasimhan’s promotion to Executive Vice President – Marketing, Asia-Pacific Division indicates that Colgate is retaining and redeploying its India leadership talent internationally. ^[10]
• External operating experience in India: Anandani brings approximately three decades across sales, marketing, general management and leadership roles, according to media coverage. ^[11]
• Strategic implication: The appointment appears designed to combine Colgate’s global operating system with a fresh India-market perspective. However, the appointment disclosure does not assign Anandani a new portfolio, channel or mass-market mandate. ^[1]

Comparison with relevant FMCG peers

Dabur India — external India-business hire under a global CEO

Dabur has adopted the closest comparable structure, although it is an Indian FMCG company rather than a direct MNC peer. Mohit Malhotra was elevated to Whole-time Director and Global CEO, while Herjit Bhalla was appointed CEO of the India business and reports to him. Bhalla came from Hershey and had earlier held leadership roles at Hindustan Unilever and Metro Cash & Carry. ^[12]

This is a deliberate global-versus-domestic role split: the group CEO handles the broader international agenda while an externally sourced operator focuses on India execution. Colgate’s move is less structurally separated because Anandani is taking the principal India MD & CEO role, but both companies are using internationally experienced consumer executives to refresh domestic execution.

Procter & Gamble Hygiene & Health Care — category-level internal continuity

The reported PGHH transition is more clearly a continuity handover within a core category. Mohit Pradhan is scheduled to take over as Vice President and Category Leader for Feminine Hygiene from Girish Kalyanraman, who transitions on July 1, 2026; Pradhan’s formal start is reported as August 1, 2026. ^[13]

The appointment is described as consistent with P&G-style internal succession planning and is focused on protecting continuity in the feminine-hygiene franchise. ^[13] This contrasts with Colgate, where the India CEO change combines an internal promotion out of the role with an incoming executive identified externally.

Gillette India — company-specific comparison not established

A company-specific CEO or senior-leadership succession strategy for Gillette India is not reported in the cited material. PGHH’s category-level transition should not be generalized to Gillette without direct evidence.

Emami — outside the direct MNC comparison

Emami is an Indian FMCG comparator rather than an MNC peer. A relevant leadership-succession event or appointment rationale for Emami is not reported in the cited material.

Cupid — outside the relevant FMCG succession set

Cupid is not a like-for-like MNC FMCG leadership comparator, and a relevant succession disclosure is not reported in the cited material.

Premiumization versus mass-market strategy

The leadership change does not currently indicate a reversal of premiumization. Colgate’s stated strategic direction remains centred on premium oral care, including whitening, gum care, premium toothbrushes and science-backed products. Management has described premiumization as a core growth pillar, alongside technology and brand investment. ^[14]

The more important point is that Colgate’s strategy is dual-track rather than premium-only:

• Premiumization for value and mix: higher-value oral-care products and digital channels are intended to raise consumer value, improve product stickiness and support pricing power. ^[14]
• Mass-market expansion for penetration and frequency: the company is also seeking to increase brushing frequency, particularly in rural India, where basic category adoption remains underdeveloped. ^[14]

Accordingly, Anandani’s appointment is more consistent with a premium-led strategy requiring stronger commercial execution than with an immediate shift back toward low-end volume. The Kenvue background may be relevant to consumer-health portfolio development and market expansion, but there is no disclosed mandate linking his appointment to a mass-market reset.

What would demonstrate a genuine shift: greater emphasis on entry-price packs, rural distribution, affordable innovations and volume-led growth at the expense of premium mix. Until such changes appear in management commentary, portfolio actions or channel strategy, the appointment should be interpreted as a leadership and execution refresh within the existing premiumization-plus-penetration framework.